PEN NYSE Week ended 31 Jul 2026

Weekly Investor Report

Penumbra Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 321.2 USD
0.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 70.8% of its 52-week range. The latest completed week returned 0.8%, after a 0.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bearish with 53/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 43 out of 100
Latest Close 321.2 USD 31 Jul 2026
1W Return 0.8% latest completed week
4W Return 0.8% short-term follow-through
12W Return -0.3% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.8% Latest completed week; four-week move 0.8%. Indicator stack 28/37 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 53/100 conviction; expected move 3.3%. News sentiment 58/100 65 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -2.7% below the Trend Line and sits at 70.8% of its 52-week range. The latest completed week returned 0.8%, after a 0.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2712-week average 0.36

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.8% over four weeks, -0.3% over 12 weeks, and 32.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.8%
4W0.8%
12W-0.3%
26W-10.3%
52W32.2%
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.89Latest activity-pressure read.
Pressure change40.8%Four-week change in activity pressure.
Leadership-3.54Latest relative-leadership reading.
RS change-9.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum81/100Medium-term price momentum. Underlying universe rank 20; rank 1 is best.
Growth95/100Revenue and earnings growth. Underlying universe rank 6; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework10/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
73.3x
Price divided by trailing earnings.
Price / sales
8.6x
Market value relative to trailing revenue.
EV / EBITDA
56.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.4%
Gross profit retained from each unit of revenue.
Operating margin
14.0%
Operating profit retained from revenue.
Free-cash-flow margin
23.4%
Free cash flow generated from revenue.
Return on invested capital
11.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
17.3%
Latest one-year revenue growth.
EPS growth
305.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
63.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

PEN shows bearish options pressure with a 53/100 conviction score, put-call volume ratio of 6.00, expected move of 3.3%, and Sharemaestro trend signal inactive.

Conviction53/100
Expected move3.3%
Put/call volume6.00
Pressure-83
Speculation8
Volatility23
Trend agreement54
Open options detail
Insider activity0 / 2

0 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 65 relevant articles.

23 positive · 42 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move3.3%Nearest-chain priced movement where available.
52-week drawdown-11.4%Distance below the 52-week high.
13-week volatility1.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+2.0%Week of 22 May.
Worst week-4.8%Week of 6 Feb.
Latest week+0.8%Week of 31 Jul.

Shape of recent returns

Strong gains0
Modest gains10
Flat weeks0
Modest losses15
Sharp losses1
Recent vol1.1%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -1.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis12/100

Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.27; 3 reversal markers Factors51/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 73; Small Cap Core rank 100 SVQF10/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 907.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options39/100

PEN shows bearish options pressure with a 53/100 conviction score, put-call volume ratio of 6.00, expected move of 3.3%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 3.3% Sentiment58/100

Weighted news tone is neutral across 65 relevant articles.

Penumbra (PEN) Revenue Climb Meets Profit Squeeze And Premium Valuation Insiders0 / 2

0 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026321.2 USD0.8%330.2 USD258.4 USD-0.89-3.541.8MOff
24 Jul 2026318.7 USD0.1%329.9 USD258.0 USD-1.13-3.082.4MOff
17 Jul 2026318.3 USD0.1%329.8 USD257.9 USD-1.32-3.522.4MOff
10 Jul 2026318.1 USD-0.1%329.7 USD257.8 USD-1.48-4.841.2MOff
3 Jul 2026318.6 USD0.6%329.5 USD257.8 USD-1.50-3.251.4MOff
26 Jun 2026316.6 USD-0.2%328.9 USD257.9 USD-1.45-1.662.0MOff
19 Jun 2026317.2 USD-0.5%328.1 USD258.0 USD-1.43-3.771.8MOff
12 Jun 2026318.7 USD-0.6%327.2 USD258.1 USD-1.22-2.472.0MOff
5 Jun 2026320.5 USD0.7%325.9 USD258.3 USD-1.18-1.372.3MOff
29 May 2026318.3 USD-3.2%324.1 USD258.3 USD-1.15-4.521.7MOff
22 May 2026328.7 USD2.0%321.0 USD258.3 USD-1.09-0.132.5MOn
15 May 2026322.3 USD0.0%318.5 USD258.1 USD-1.12-1.331.7MOn
8 May 2026322.2 USD-1.0%316.1 USD258.1 USD-1.00-1.332.4MOn
1 May 2026325.3 USD-1.4%314.0 USD258.1 USD-0.871.542.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.